MSB 2.70% 95.0¢ mesoblast limited

"FDA approval for surgical therapies requires concomitant...

  1. 521 Posts.
    lightbulb Created with Sketch. 1481
    "FDA approval for surgical therapies requires concomitant improvement in both pain and function" (per previous MSB info).

    1st time 24 months results presented re 100 patient trial... quite significant IMO ( we previously knew 12 months only).
    Based on the 24 month results - FDA approves Phase III commencement.

    Good Luck Holders.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
0.025(2.70%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 96.8¢ 93.5¢ $4.207M 4.417M

Buyers (Bids)

No. Vol. Price($)
3 42268 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.0¢ 48002 3
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.